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Abstract
Background: Australia has an enviable record of safety for women in childbirth. There is nevertheless growing
concern at the increasing level of intervention and consequent morbidity amongst childbearing women. Not only
do interventions impact on the cost of services, they carry with them the potential for serious morbidities for
mother and infant.
Models of midwifery have proliferated in an attempt to offer women less fragmented hospital care. One of these
models that is gaining widespread consumer, disciplinary and political support is caseload midwifery care. Caseload
midwives manage the care of approximately 35-40 a year within a small Midwifery Group Practice (usually 4-6
midwives who plan their on call and leave within the Group Practice.) We propose to compare the outcomes and
costs of caseload midwifery care compared to standard or routine hospital care through a randomised controlled
trial.
Methods/design: A two-arm RCT design will be used. Women will be recruited from tertiary women’s hospitals in
Sydney and Brisbane, Australia. Women allocated to the caseload intervention will receive care from a named
caseload midwife within a Midwifery Group Practice. Control women will be allocated to standard or routine
hospital care. Women allocated to standard care will receive their care from hospital rostered midwives, public
hospital obstetric care and community based general medical practitioner care. All midwives will collaborate with
obstetricians and other health professionals as necessary according to the woman’s needs.
Discussion: Data will be collected at recruitment, 36 weeks antenatally, six weeks and six months postpartum by
web based or postal survey. With 750 women or more in each of the intervention and control arms the study is
powered (based on 80% power; alpha 0.05) to detect a difference in caesarean section rates of 29.4 to 22.9%;
instrumental birth rates from 11.0% to 6.8%; and rates of admission to neonatal intensive care of all neonates from
9.9% to 5.8% (requires 721 in each arm). The study is not powered to detect infant or maternal mortality, however
all deaths will be reported. Other significant findings will be reported, including a comprehensive process and
economic evaluation.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12609000349246
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Background
Australia has an enviable record of safety for women in
childbirth [1]. There is nevertheless growing concern at
the increasing level of intervention, cost and consequent
morbidity amongst childbearing women [2]. Rising
intervention rates are most clearly reflected in the
changes in rates of caesarean section which have
increased over time. In 1991, only 19.0% of births were
via caesarean section. By 2006, 31% of all births were via
caesarean [1]. In addition to caesarean section, popula-
tion based research in Australia revealed that amongst
women with uncomplicated pregnancies, a third of all
women currently have some form of intervention such
as an induction or augmentation of their labour com-
bined with an epidural [3]. Cost modelling of these
interventions showed a relative cost increase of up to
50% for low risk primiparous women and up to 36% for
low risk multiparous women as labour interventions
accumulated [4].
Not only do interventions impact on the cost of ser-
vices, they carry with them the potential for serious
morbidities for mother and infant. Over a decade ago
a large population based study in Victoria found that
more than nine out of ten women had at least one sig-
nificant medical complaint after giving birth [5]. Com-
pared with spontaneous vaginal births, women having
an instrumental birth had increased odds for perineal
pain (OR 4.69, 95%CI 3.2-6.8) sexual problems (OR
2.06, 95% CI 1.4-3.0), and urinary incontinence (OR
1.81, 95% CI 1.1-2.91) [5]. Other studies have shown
that a first birth by forceps delivery can cause a two-
fold increase in the risk of having persistent faecal
incontinence, and in about half these cases faecal
incontinence may persist for at least five years [6].
Caesarean births carry the risk of increased perinatal
mortality in subsequent pregnancies[1,7,8] and the risk
of morbidity associated with surgery[9] and possible
maternal complications in subsequent pregnancies (e.
g., uterine rupture, placenta praevia, and placenta
accreta) [10,11]. Operative birth also increases the
fetal risks of respiratory distress syndrome [12] persis-
tent pulmonary hypertension,[13] and admission to
special care or neonatal intensive care nurseries parti-
cularly if the caesarean section is performed before the
onset of labour [12,14,15]. Australian research into the
rates of admission to neonatal intensive care of term
babies of low risk women found the overall rate of
admission is currently as high as 7.32% amongst low
risk women [15].
An intervention that could lower rates of caesarean
section, instrumental birth and epidural analgesia with
no increase in mortality or morbidity for the mother or
baby would improve the quality of maternity care,
reduce unnecessary or harmful interventions and be
cost effective.
No intervention reported in the Cochrane Library of
systematic reviews of pregnancy and childbirth has had
a more significant effect on lowering rates of interven-
tion during childbirth than ‘continuity of care’ [16].
However, in Australia at present fewer than10% of
women have access to continuity of care [17] and some
women may meet up to 20 different midwives or care-
givers from the time they begin antenatal care until the
baby is born and the mother is discharged from postna-
tal care. Models of midwifery have proliferated in an
attempt to offer women more continuity of care. We
proposed to compare the outcomes and costs of case-
load midwifery care compared to standard or routine
hospital care for childbearing women through a rando-
mised controlled trial.
Caseload midwifery
The aim of caseload midwifery is to provide women
with the same midwife (or small group practice of mid-
wives) to look after them from booking in through until
the time they are discharged from care at about four to
six weeks following the birth of the baby.
Despite the substantial health care costs associated
with maternal and infant health, there are minimal data
on the cost effectiveness of maternity care offered in the
public (or private sector) in Australia. Allocating finite
resources in ways that are most effective in improving
health outcomes continues to be a challenge [18]. As yet
there is no cost benefit analysis of the caseload midwif-
ery model for women of all risk anywhere in the world.
There remains continuing uncertainty and debate
about the risks, benefits and costs of midwifery led
models versus other models of maternity care [16,19,20].
Several large national reviews [17,21] and a workforce
study [22] identified that the current limited and inflex-
ible scope of practice negatively affects Australian mid-
wives’ sense of satisfaction with their employment. The
Commonwealth Health Workforce Review [23] found
that workforce shortages, inflexibilities and inefficiencies
in workplace arrangements are major contributors to
poor health outcomes.
We plan to implement and evaluate Midwifery Group
Practices at two large teaching maternity hospitals in
Australia to compare the outcomes and costs of case-
load midwifery care and standard or routine hospital
care for childbearing women.
Ethical approval and site specific ethical approval was
received from all University and Area Health Service
Human Research Ethics Committees governing the
study sites: University of Sydney HREC approval REF
NO 12068; Lead HREC approval REF NO 0805072M.
Tracy et al. BMC Pregnancy and Childbirth 2011, 11:82
http://www.biomedcentral.com/1471-2393/11/82
Page 2 of 8
Methods/design
The study uses a pragmatic two arm, unblinded rando-
mised controlled design, to compare caseload midwifery
care with standard maternity care.
Aims and Objectives
The aim of the study is to compare the outcomes and
costs of caseload midwifery care compared to standard
or routine hospital care for childbearing women through
a randomised controlled trial.
Primary objectives are to determine whether women
receiving caseload midwifery care experience the same
rates of caesarean section, instrumental births and use
of epidural analgesia compared to women receiving rou-
tine care and to determine whether women with identi-
fied risk factors at the onset of labour experience the
same rates of neonatal morbidity (including admission
to the neonatal intensive care unit), and perinatal mor-
tality compared to routine care.
We will determine whether caseload midwifery care
costs the same as routine maternity care and whether
women who receive caseload care experience the same
potential benefits and consequences of postnatal care as
women receiving routine maternity care.
Secondary objectives are to determine whether mid-
wives offering caseload practice experience the same
levels of work satisfaction and the same levels of pro-
ductivity as midwives working in conventional rostered
and rotating shifts; and to determine whether obstetri-
cians working with caseload midwives experience the
same levels of professional satisfaction as obstetricians
working with rostered midwives in the routine work set-
ting. We will also determine the rates of postnatal
depression and smoking in pregnancy.
Outcome measures
The primary maternal outcomes of the study are the
proportion of women in each arm of the study:
• having caesarean section operations,
• instrumental births
• spontaneous vaginal births
• epidural analgesia for labour and birth
The primary neonatal outcomes of the study are the
proportion of infants in each arm of the study who have:
• Apgar scores less than or equal to 7 at 5 minutes
• preterm birth (less than 37 completed weeks)
• admission to special care nursery or neonatal
intensive care unit;
Secondary maternal outcomes include the proportion
of women in each arm of the study who have:
• antenatal admissions
• induction and/or augmentation of labour
• women who are breastfeeding at six weeks and six
months
Cost outcomes include:
• Comparative average cost per mother and baby
episode as an AR-DRG
In addition to the primary outcomes listed above we
will report on
Other neonatal outcomes including: low birth weight
(less than 2500 g); length of neonatal hospital stay; neo-
natal convulsions; neonatal trauma (fracture or palsies);
neonatal resuscitation: use of neonatal respiratory sup-
port (mechanical ventilation/CPAP) and/or perinatal
mortality.
Other maternal outcomes include the rate of maternal
complications (e.g. hypertension, ante partum haemor-
rhage, cord prolapse etc) and miscarriages in both the
intervention and control arms; the proportion of women
who have perineal trauma (episiotomy, 1st, 2nd, 3rd or
4th degree perineal tear, sutures required); postpartum
haemorrhage (more than 500 ml or any amount which
causes deterioration in maternal health; and/or blood
transfusion); and serious maternal complications (e.g.
intensive care unit admission or death).
Although the study is not powered to detect other
related outcomes including measures of perinatal mortal-
ity (e.g. fetal or neonatal death,) or maternal mortality,
these events will be reported in full.
Study population
Pregnant women booking in to give birth at one of two
sites during the recruitment period will be invited to
participate in the study and will be randomly allocated
to caseload midwifery care versus routine care according
to a post-consent method using accepted concealment
measures endorsed by the NHMRC. The two sites are -
large tertiary maternity hospitals in Sydney (site 1) and
Brisbane (site 2).
Study Power
With 750 women or more in each of the intervention
and control arms the study is powered (based on 80%
power; alpha 0.05) to detect a difference in caesarean
section rates of 29.4 to 22.9%; instrumental birth rates
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from 11.0% to 6.8%; and rates of admission to neonatal
intensive care of all neonates from 9.9% to 5.8%
(requires 721 in each arm). The study is not powered to
detect infant or maternal mortality, however all deaths
will be reported. Secondary outcomes will include rates
of smoking cessation (eg 14.8% to 9.9% needing 747
women in each arm) and breastfeeding initiation and
duration. We have calculated a sample to include a 30%
attrition rate; therefore we aim to recruit a total of
1,950 women. All outcome measures identified by the
Cochrane Protocol [19] will be collected. Individual hos-
pital data bases and a purposefully designed data base
will collect all primary and secondary outcome and pro-
cess measures in addition to most cost outcome
measures.
Definitions of Control and Intervention
The lead professional for the continuum of the antena-
tal, intrapartum and postnatal periods will be the criter-
ion for the classification of care as caseload midwifery
or routine (medical doctor-led) care [19].
CONTROL Standard or Routine care: the designated
obstetrician is the lead professional. Women are booked
under the hospital consultant on call for the day of
booking, and the responsibility for the delivery of care,
from initial booking through the postnatal period, rests
with the public maternity hospital service. Women allo-
cated to the control group can choose from the standard
hospital options for care which include midwives clinic
antenatally; GP shared care antenatally; followed by gen-
eral public hospital care in labour and in the postnatal
ward. This may involve women seeing a different mid-
wife for every visit; care by junior medical obstetric staff;
or shared care with an accredited general medical prac-
titioner (GP) (i.e. the GP provides the woman’s antenatal
care, usually nearer to her home, but the woman is
booked for extra antenatal care, labour, birth and post-
natal care at the hospital). Women may see an obstetri-
cian during pregnancy with other referrals or
consultation as necessary. When women come into the
hospital for labour, birth and postnatal care they will be
cared for by whichever midwives and doctors are ros-
tered for duty. For women in the control and interven-
tion arms at each site the care will be provided
according to the same hospital guidelines and protocols
of each site.
INTERVENTION Caseload Midwifery care: Women
allocated to the caseload intervention will receive
antenatal, intrapartum and postpartum care from a
named caseload midwife who will be backed up when
necessary by other caseload midwives from within her
Midwifery Group Practice. Each named caseload mid-
wife works in a Midwifery Group Practice of four full
time equivalent midwives each working a cycle of 152
hours during each four week period. Caseload midwives
must be independent of the hospital rosters and
employed on an annual salary to allow for workload to
be self managed within each Midwifery Group Practice
and responding to the needs of the women in their case-
load. The named midwife is on call for the woman’s
labour and birth except in designated circumstances
such as annual leave; sick leave; having more than one
woman in labour; or if it is on one of the two days per
week that the named midwife is scheduled to not work
or be on call. Care will then be provided by a back-up
caseload midwife from the Midwifery Group Practice.
The caseload midwife is the woman’s lead professional
but one or more consultations with medical doctors
may be part of routine practice [24]. Midwifery care is
offered simultaneously with medical care if required. In
addition to providing care until after the birth of the
baby, the named caseload midwife (or a back up mid-
wife from the Midwifery Group Practice) will attend the
hospital on most days to provide some postnatal care
until discharge and will provide full domiciliary care fol-
lowing discharge from hospital. Care will be provided
according to hospital guidelines and protocols for up to
six weeks following birth.
Trial Eligibility
Women will be eligible for trial entry if they are less
than 24 completed weeks of pregnancy and a minimum
of 18 years old at booking in. At the participating cen-
tres research midwives will recruit the required number
of women in the experimental arm over 24 months. We
will enroll 1950 women in anticipation of no more than
a 30% attrition rate.
Exclusions
Women will be excluded from the trial if they are elec-
tively booked to give birth via caesarean section at the
time of booking in; or are already booked with a named
care provider (Obstetrician/GP/midwife).
Trial Recruitment
At site [1] women will be recruited using three strate-
gies depending on point of first contact.
1. When the woman contacts the hospital by phone
for booking, the administration desk will send out
information leaflets informing women of (a) the
opportunity to book with a caseload midwife as part
the care offered at the hospital and (b) inviting them
to participate in the study before the first visit to the
hospital antenatal clinics. Women will attend the
hospital antenatal clinic for their booking visit. At
the first visit (booking clinic) women will be seen by
a research midwife who ascertains if the woman has
previously received written information and if so,
she will be invited to participate. Following written
consent, the midwife will randomise the woman to
the intervention caseload midwifery care with a
Tracy et al. BMC Pregnancy and Childbirth 2011, 11:82
http://www.biomedcentral.com/1471-2393/11/82
Page 4 of 8
named midwife or routine care via a central tele-
phone randomisation service (NH&MRC method);
and enter details on the Trial Register and Daily Log
Book. (The NHMRC administered telephone rando-
misation method guarantees both random sequence
generation and allocation concealment according to
CONSORT guidelines).
2. When a booking referral from the woman’s Gen-
eral Practitioner is sent to the hospital, the adminis-
tration desk contacts the woman and informs the
woman of (a) the opportunity to book with a case-
load midwife as part the care offered at the hospital,
and (b) if eligible invite them to participate in the
study before the first booking visit. Interested
women will be sent information leaflets. The woman
is contacted by phone by the research midwife to
ensure the information has been received, assess the
woman’s understanding of the study, answer any
questions, and obtain verbal consent to participate
and be randomised. Once verbal consent is obtained
the trial procedure is the same as that above and her
details are entered onto the Trial Register and Daily
Log Book. Consent is formalised in writing at the
first booking visit. At this stage, if the woman
declines to give written consent or is ineligible, she
is not enrolled in the trial. Women not wishing to
participate in the study will progress through the
antenatal clinic as usual.
3. When the woman has not received written infor-
mation, at the booking clinic, she will be seen by a
research midwife, who will provide her with written
information and an opportunity to discuss the study.
Before being invited to participate in the study, the
woman will be given the opportunity to defer her
decision to participate until the next antenatal
appointment where she will be seen again by the
antenatal clinic midwives and the research midwife.
If the woman wishes to decline or accept the invita-
tion to participate at this first visit, she may do so.
She may contact the research midwives at a later
time to participate in the study. Once women have
given written consent to be involved in the trial, the
trial procedure is the same as that above. Details of
these women will also be recorded in the Trial Reg-
ister and Daily Log Book Women not wishing to
participate in the study will progress through the
antenatal clinic as usual.
At Site 2 pregnant women will be randomly allocated
to caseload midwifery care or routine care during preg-
nancy.
1. On receipt of referral from the general practi-
tioner, the GP Liaison will identify women eligible
for caseload care. This process is guided by availabil-
ity of places on caseload group practice models of
care in association with the locality of the home
address of women who book.
2. Women who qualify on these grounds will be tel-
ephoned to be informed of their acceptance to book
at Site 2 and the availability of caseload midwifery
care in their area. They will have the models of care
briefly outlined, and be invited to participate in the
trial.
3. Interested women will receive a brochure on
models of care, and a M@NGO trial brochure in the
post.
4. One week following postage, the research midwife
will provide a follow up phone call to ensure the
information was received, assess the woman’s under-
standing of the study, answer any questions, and
obtain verbal consent to participate and be rando-
mised. We do not expect that this will create unne-
cessary delays as at present women may wait several
weeks before they receive a letter confirming their
acceptance to Site 2, with the models of care bro-
chure and a booking appointment.
5. Once verbal consent is obtained and documented,
the research midwife will randomise the woman to
caseload or routine care via a central telephone ran-
domisation service (NH&MRC method); and enter
details onto the Trial Register and Daily Log Book
6. At the first booking visit women who were tele-
phone randomised to take part in the study will con-
firm and formalise participation in the trial by giving
written consent at the first booking visit in the
home.
7. In the standard care model written consent will be
obtained at the first booking visit in the hospital or
community-based antenatal clinic.
8. At this stage, if the woman declines to given writ-
ten consent or is ineligible (meets exclusion criteria)
she is excluded from trial, and her care will be ‘as
usual’ i.e. standard care.
Once women have given written consent to be
involved in the trial, the trial procedure is the same as
Site 1 above. Women not wishing to participate in the
study will progress through the hospital or community
antenatal clinics as usual. Details of these women will
also be recorded in the Trial Register and Daily Log
Book.
Differences between Site 1 and Site 2
Although there is a slight difference in the recruitment
process for the trial at the two sites, the integrity of the
randomisation process is safeguarded by the fact that
there is equipoise in the decision process for women
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regarding which model of care they will receive. Women
who have a stated preference for either model are not
invited to be randomised to a model of care. The pro-
posed recruitment method for Site 2 differs slightly
from the process employed at site 1 on two counts:
i. At site 1 all women attend a first booking visit at
the hospital antenatal clinic before they are allocated
to a model of care, including caseload care. At Site 2
women are allocated to a model of care, including
caseload care by the GP Liaison, prior to the first
booking visit.
ii. At site 1 the first booking visit occurs in the
antenatal clinic, which enables research midwives’ to
provide information about the trial and obtain writ-
ten consent. At Site 2 women are offered informa-
tion by telephone and the initial consent is received
by telephone. All women allocated to MGP have a
home booking visit and do not attend the antenatal
clinic at all. It is not feasible for the research mid-
wife to accompany MGP midwives to every home
visit to give information about the trial and obtain
written consent in the first instance. See above the
process for Site 2 to further clarify.
Analysis
Analysis will be by intention to treat which will include
withdrawals and losses to follow up. There should be
minimal differences in the baseline characteristics
between groups due to the randomisation process. Sta-
tistical adjustment may be needed if important differ-
ences arise in baseline characteristics. Relative risks with
95% confidence intervals for the primary outcomes will
be calculated. Measures of categorical data will be ana-
lysed with chi-squared tests and continuous data will be
analysed with t-tests. Logistic regression and multiple
linear regressions will be used if necessary to adjust for
confounding for binary and continuous outcomes.
Risk will be controlled for in the statistical analysis
and identified at the onset of labour rather than at
enrolment in the study. Women will be categorised
dichotomously as ‘at low risk’ and ‘not low risk’ accord-
ing to maternal risk status at the time of the onset of
labour. The risk factors and levels of risk are well
defined in the ACM Guidelines [24] as level B or C -
however, all definitions of risk will be available in the
publication of the study.
Interim Analysis
A data monitoring group will look for differences
between the groups that may be larger than expected as
well as unanticipated adverse effects that may occur
[25]. After 50% of the women have given birth a
difference of at least three standard deviations in interim
analysis of a major endpoint is needed to justify stop-
ping the trial. (All perinatal deaths will be reviewed by a
multidisciplinary adverse events committee blinded to
treatment allocation.) While it is not possible to blind
participants to the model of care they receive, we will
endeavour to blind the outcome assessments.
Cost methods
As no single outcome measure can encapsulate all
benefits of treatment, the economic evaluation is based
on a cost-consequence analysis [26]. We will determine
the importance of each outcome measure relative to
the costs if the caseload midwifery care and routine
care costs are similar. The costs will be presented in
terms of average cost per mother and baby and
reported as a ‘mother/baby episode’ which includes the
full episode of care. Costs will also be presented in
actual Australian Revised Diagnosis Related Group
(ARDRG) related funding terms for each arm of the
study.
Expenditure data will be obtained from each hospital’s
financial system including detailed patient-level data on
inpatient contacts for the mother and baby and the data
related to the costing of medical and midwifery contact
time during each mother/baby episode.
Qualitative methods
Women’s Questionnaires
Women will be asked to assess the service through qua-
litative surveys offered at thirty six weeks, six weeks and
six months postpartum. At six weeks women will be
offered a survey tool based on the Oakley et al ‘social
support’ questionnaire [27]. This questionnaire is vali-
dated for use amongst women considered to be both
high and low risk as well as those of lower socio-eco-
nomic status. At six months women will be offered the
36 item short form SF36 [28] which will provide subjec-
tive accounts of health following childbirth. We have
chosen these tools rather than the conventional satisfac-
tion type surveys because satisfaction may reflect
whether or not expectations have been met rather than
whether or not benefit has been achieved in the eyes of
the woman and her family.
Questionnaires for Staff
The team plans to collaborate with researchers from the
department of Organisation and Management at the
Australian School of Business based at UNSW to under-
take a rigorous assessment of employees’ motivation,
well-being and emotion management strategies, as well
as the drivers and outcomes of these factors particularly
in relation to measuring the effect of a new model of
delivering midwifery care, compared to traditional mod-
els of delivering midwifery care.
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Confidentiality and Data Security
Participants in the trial will be identified by a study
number only, with a master code sheet linking names
with numbers being held securely and separately from
the study data. See ethics section for storage and dispo-
sal details.
Group Allocation
The randomisation schedule will be prepared by a
researcher not involved with treatment allocation. Fol-
lowing written informed consent from the woman, the
research midwife will telephone the randomisation ser-
vice. Details of the woman’s consent and trial entry
data will be recorded. The midwife will then be
informed of the group (caseload midwifery or routine
hospital care) to which the woman has been randomly
allocated and the woman will be issued with a unique
4 digit study number. Study group allocation will be
recorded on the Trial Register and Daily Log Book. To
assess the comparability of the study groups, baseline
demographic and medical information will be collected
from the medical record at the time of entry into the
study. Because the structure of practice is so different;
there should be minimal opportunity for cross overs
to occur. No attempt will be made to blind the identi-
fication of women randomised to either arm of the
study.
Justification for RCT
The strength of the proposed experimental randomised
design is the capacity to determine causality between
the outcome variables (dependent variables) and the
type of care received by women in each of the two
groups (independent variables).
In a random assignment to each nominal group: the
probability of being assigned to intervention or control
is not dependent on pre-trial choice or preference and
any other baseline patient characteristics. Women not
allocated a caseload midwife will be cared for as usual
in the routine hospital group by rostered midwives and
rostered medical personnel. Some women may receive
their antenatal care in a GP/shared care model and
enter the hospital at the time of birth to be cared for by
the rostered midwifery and medical staff on duty. Sub-
jects will be analysed within the group to which they
were allocated, irrespective of whether they experienced
the intended intervention (intention to treat analysis).
All exclusions will be reported.
Discussion
This trial will provide a comprehensive and rigorous
evaluation of caseload midwifery maternity care. The
evidence that this trial can provide is long overdue for
maternity policy makers and service providers who are
responsible for the effective design, delivery and costs of
services that are the most frequent cause of hospitalisa-
tion in Australia today.
Restructuring maternity services to introduce caseload
midwifery care involves radical changes to conventional
or routine midwifery and obstetric practices [29-31]. All
these changes make an impact on health planning and
the allocation of finite resources [18]. Many innovations
are introduced in a relative policy vacuum. Models of
maternity care are no exception. This proposed trial is
significantly innovative because it is designed to be
undertaken on as a multisite study in two different
states within Australia and includes women of all risk
rather than low risk women. Because our proposed trial
meets the criteria of the Cochrane Systematic Review of
midwifery caseload care in methods; randomisation;
definitions of the intervention and control arms; out-
come measures and statistical analysis,[19] the results
will contribute to a wider inquiry and meta-analysis in
the future.
In addition to evidence on the experiences of women
receiving caseload midwifery care and the experiences of
obstetricians and midwives offering caseload care, the
outcomes of the proposed trial will contribute:
1. Level 1 evidence of the safety and effectiveness of
having a known caseload midwife for the continuum
of pregnancy birth and postnatally.
2. Level 1 evidence of the safety and effectiveness of
caseload midwifery care for women of all risk.
3. Level 1 evidence on the cost effectiveness of case-
load midwifery care and routine obstetric care for all
women.
4. ‘Australian randomised controlled trial data to the
Cochrane systematic review of midwife led care[19].
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